Investor News and Ad-hoc News

All

Business segments

Fresenius Fresenius Medical Care Fresenius Kabi Fresenius Helios Fresenius Vamed

Topics

Financial Reporting Corporate Actions Financing M&A / Joint Ventures Other

Time span

Contact

Senior Vice President Investor Relations
Head of Investor Relations
T: +49 (0) 6172 608-97033
nick.stone@fresenius.com

Ad Hoc News

Contact

Senior Vice President Investor Relations
Head of Investor Relations
T: +49 (0) 6172 608-97033
nick.stone@fresenius.com

Information & Order Service

Stay informed about the latest news and developments at our Group by subscribing to our Investor News and/or to the Fresenius Brief News. These services are free of charge and may be cancelled at any time.

I am a private investor

I am an institutional investor

Title

First Name

Last Name

Company

Department

Street / Number

Postal Code / City

Country

E-mail

Telephone number

Please send me via email

Fresenius Brief News

English

German

Fresenius Investor News

English

German

Do you have other questions or need any more information?
Please send us a message:

By submitting, you agree to our privacy policy.
To unsubscribe to these services, please send a brief e-mail to ir-fre@fresenius.com or call +49 (0) 6172 608-2470.